Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study
about
Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in HIV-positive adultsUrine lateral flow lipoarabinomannan assay for diagnosing active tuberculosis in adults living with HIVXpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adultsPET/CT imaging of Mycobacterium tuberculosis infectionDetection of lipoarabinomannan (LAM) in urine is indicative of disseminated TB with renal involvement in patients living with HIV and advanced immunodeficiency: evidence and implications.HIV and tuberculosis--science and implementation to turn the tide and reduce deathsPoint-of-care assays for tuberculosis: role of nanotechnology/microfluidics.Point-of-care diagnosis of tuberculosis: past, present and futureAdvances in addressing technical challenges of point-of-care diagnostics in resource-limited settings.Detection of lipoarabinomannan (LAM) in urine is an independent predictor of mortality risk in patients receiving treatment for HIV-associated tuberculosis in sub-Saharan Africa: a systematic review and meta-analysisDiagnosis and management of miliary tuberculosis: current state and future perspectivesPredictors of tuberculosis in first 6 months after initiation of antiretroviral therapy: a case-control studyA bispecific antibody based assay shows potential for detecting tuberculosis in resource constrained laboratory settingsTime to treatment and patient outcomes among TB suspects screened by a single point-of-care xpert MTB/RIF at a primary care clinic in Johannesburg, South AfricaSoluble markers of the Toll-like receptor 4 pathway differentiate between active and latent tuberculosis and are associated with treatment responsesThe diagnostic accuracy of urine-based Xpert MTB/RIF in HIV-infected hospitalized patients who are smear-negative or sputum scarceSelf-tests for influenza: an empirical ethics investigationThe biology of mycobacterium tuberculosis infection.Emerging technologies for monitoring drug-resistant tuberculosis at the point-of-careMycobacterium tuberculosis bacteremia in a cohort of hiv-infected patients hospitalized with severe sepsis in uganda–high frequency, low clinical suspicion [corrected] and derivation of a clinical prediction score.Impact of human immunodeficiency virus and CD4 count on tuberculosis diagnosis: analysis of city-wide data from Cape Town, South Africa.Urine lipoarabinomannan testing for diagnosis of pulmonary tuberculosis in children: a prospective study.Diagnostic point-of-care tests in resource-limited settingsTuberculosis and HIV co-infection in children.Serological diagnostic assays for HIV-associated tuberculosis in sub-Saharan Africa?Causes and outcome of hospitalization among HIV-infected adults receiving antiretroviral therapy in Mulago hospital, Uganda.Comparative performance of urinary lipoarabinomannan assays and Xpert MTB/RIF in HIV-infected individualsPoint-of-care lateral flow assays for tuberculosis and cryptococcal antigenuria predict death in HIV infected adults in UgandaDiagnostic accuracy of a urine lipoarabinomannan strip-test for TB detection in HIV-infected hospitalised patients.Prognostic value of a quantitative analysis of lipoarabinomannan in urine from patients with HIV-associated tuberculosis.Cost-effectiveness of novel algorithms for rapid diagnosis of tuberculosis in HIV-infected individuals in Uganda.Update on opportunistic infections in the era of effective antiretroviral therapyDiagnostic accuracy of a rapid urine lipoarabinomannan test for tuberculosis in HIV-infected adultsLipoarabinomannan in urine during tuberculosis treatment: association with host and pathogen factors and mycobacteriuriaPrevalence of national treatment algorithm defined smear positive pulmonary tuberculosis in HIV positive patients in Brazzaville, Republic of CongoPoint-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review.Nuclear imaging: a powerful novel approach for tuberculosis.Diagnostic delays and clinical decision making with centralized Xpert MTB/RIF testing in Durban, South Africa.Management of HIV-associated tuberculosis in resource-limited settings: a state-of-the-art review.Survival among patients with HIV infection and smear-negative pulmonary tuberculosis - United States, 1993-2006.
P2860
Q24185754-21EFB3FB-CBBC-4352-80F5-098783AAEFF4Q24187533-ABFF270A-AE7D-4CE0-91FE-646D05B61354Q24200879-9357892D-9B9D-404E-8A47-575A86E826AAQ26748493-F7C71FE4-A494-4AA6-AAFA-E316D9E520D8Q26765388-85060A7B-6513-4C8F-9FB4-73667C13B4FBQ26824501-CDC2E291-8F0E-4308-93E8-2C15F50C431FQ27004505-B6218ABB-37DE-475B-B6C7-82EC679FD765Q27004667-754F718D-50E0-4117-B70E-132485CF1D61Q28072960-4D9AD35B-E1E9-4323-B1E5-6D22B57F54B9Q28073433-4E1C72B5-076E-45B8-A7A8-FA7A6DC942DDQ28393022-3EDA4F82-D365-4496-91FB-A0A5E56F75F4Q28397102-366ED4D2-EE8F-4DB2-998F-0721AD725B76Q28481078-0B28D3E0-0497-457D-B727-EB8F5899275AQ28533713-4AE22795-3CCD-4A7B-ACB0-CA3F36177C46Q28534690-74A1F8FD-8031-4BB0-80E3-452C6C66AAA2Q28727351-7C88741B-214B-4B40-9050-2370D02A47FCQ29994766-19471B64-21E2-4165-83C8-37AC80A5D8DBQ30357155-B6251218-E6D9-476D-BA3D-4D9B00CFCED5Q30397647-577F0D0D-99D4-4DBF-A978-2A8BBE52D36CQ30417688-432BE3B4-1283-41FC-9447-7D2633D2DB1DQ30653441-4B335C09-6770-43C1-85E7-99F5BA54B55CQ33576204-7A4D1D56-A3C0-40C6-9183-3A1F7162F052Q33590492-116A3B47-EB20-4A66-AC0F-4DE51608EEE1Q33592322-C9800C21-14B0-4343-A115-C06DCD5F6221Q33743476-3418E44E-CC17-4582-BFFD-BB612FE3BE97Q33751709-92473179-177B-454A-BE28-FE73CDDC20BBQ33820488-A8253665-4BC8-44E7-99B6-10E446CAAE75Q33855961-6CB78B31-F4D3-41C1-B5B7-4B1818B36E9CQ33924587-6885ACEA-B3AF-4A8C-A704-9410E1A29E53Q33975232-F2E6404D-8ADB-4EC3-988F-0F8B831CF52BQ34048848-88BF78D4-9A8F-4C6F-A4F8-DEAB81FA3F38Q34085853-30F5B8D9-E603-48E1-9B87-DE3D07C0AF63Q34098274-00F95A38-B901-4F93-BF3C-73E2CD35B64CQ34173643-04D053EB-4174-4EAD-9ED8-EBADC2990E69Q34203557-DD49473D-1C8E-4025-947A-2AABEBB2D1ECQ34247819-86A294ED-506F-4205-95D6-8BF6FE5751DBQ34315731-6F86F367-A8EF-4B0E-B33B-92413EA01641Q34340867-0C47F76C-6C56-401D-B359-42FACE18EBC7Q34455442-6F7F8AA9-A957-4560-917D-DDDE5D9A03AFQ34460644-56D26EA1-3873-4B60-9AB3-5432830EC508
P2860
Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Diagnostic accuracy of a low-c ...... l therapy: a descriptive study
@ast
Diagnostic accuracy of a low-c ...... l therapy: a descriptive study
@en
type
label
Diagnostic accuracy of a low-c ...... l therapy: a descriptive study
@ast
Diagnostic accuracy of a low-c ...... l therapy: a descriptive study
@en
prefLabel
Diagnostic accuracy of a low-c ...... l therapy: a descriptive study
@ast
Diagnostic accuracy of a low-c ...... l therapy: a descriptive study
@en
P2860
P1476
Diagnostic accuracy of a low-c ...... l therapy: a descriptive study
@en
P2093
Andrew D Kerkhoff
Monica Vogt
P2860
P304
P356
10.1016/S1473-3099(11)70251-1
P577
2011-10-17T00:00:00Z